Luteal Phase Support in ART: An Update

Ghanem, Mohamad E.; Alboghdady, Laila A.

doi:10.5772/51093

Enhancing Success of Assisted Reproduction 2012

DOI: 10.5772/51093

|View full text |Cite

Luteal Phase Support in ART: An Update

Mohamad E. Ghanem¹,

Laila A. Alboghdady²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Preprint1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Comparable Outcomes Using Oral Dydrogesterone versus Intramuscular Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study

Bachar

Haskia

Fainaru

2023

Preprint

View full text Add to dashboard Cite

Background Optimal intensive luteal support in frozen embryo transfer (FET) cycles in which a corpus luteum is not present has not been determined and several treatment regimens are currently practiced. Previous reports suggest that vaginal progesterone alone is probably insufficient. The use of intramuscular progesterone is considered efficacious but much less tolerable. The objective of this study was to compare a more tolerable regimen using micronized vaginal progesterone (MVP) and oral dydrogesterone versus MVP and intramuscular progesterone (IM) for luteal support. Methods A retrospective study of patients undergoing single blastocyst FET in a tertiary center IVF unit. All patients (n = 100) received oral estradiol in the follicular phase and supplemented with MVP for luteal phase support. One group (n = 50) received additional dydrogesterone (10 mg TID) and the other (n = 50) intramuscular progesterone (100 mg every 3 days). Results The two groups were similar with regard to age; BMI; infertility etiology and duration; and basal hormonal levels. Biochemical pregnancy rates (34% vs 42%, p = 0.54) and clinical pregnancy rates (26% vs. 36%, p = 0.39) were lower in the MVP + oral dydrogesterone group as compared to the MVP + IM progesterone group. Nevertheless, this difference was not statistically significant. Abortion rates were similar (2%) and there were no ectopic pregnancies in both groups. Conclusion This retrospective cohort study demonstrates noninferiority of MVP and oral dydrogesterone as compared to MVP and intramuscular progesterone for luteal support in FET cycles. The better profile of adverse effects and tolerability makes it a suitable protocol for FET.

show abstract

Comparable Outcomes Using Oral Dydrogesterone versus Intramuscular Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study

Bachar

Haskia

Fainaru

2023

Preprint

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Luteal Phase Support in ART: An Update

Cited by 1 publication

References 70 publications

Comparable Outcomes Using Oral Dydrogesterone versus Intramuscular Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study

Comparable Outcomes Using Oral Dydrogesterone versus Intramuscular Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study

Contact Info

Product

Resources

About